H.I.G. Capital Acquires Celerion

H.I.G. Capital Makes Growth Investment in Cleo Communications

June 9, 2021

Cloud & SaaS

H.I.G. Capital made a significant growth investment in Cleo Communications, a Rockford, Illinois–headquartered provider of ecosystem integration SaaS; terms were not disclosed. The investment will support Cleo's continued product development and market expansion as the company scales its Cleo Integration Cloud platform across manufacturing, wholesale & distribution, and logistics end-markets.

H.I.G. Capital Acquires Taconic Biosciences

February 7, 2019

Healthcare Services

H.I.G. Capital, through an affiliate, has completed the acquisition of Taconic Biosciences, a global provider of genetically engineered research models and related services. The private equity investment will partner with Taconic's management to support geographic expansion, broaden product and service offerings, and accelerate M&A-driven growth.

Hastings Equity Partners Invests in Celerity Consulting Group

July 12, 2021

Consulting

Hastings Equity Partners announced a platform investment in Celerity Consulting Group, a San Francisco–based information management and utility consulting firm. Hastings will partner with Celerity's existing leadership team to support growth—both organic and via add-ons—to expand the firm's capabilities serving utilities, government, law firms, and corporations.

GHO Capital Acquires Velocity Clinical Research

July 15, 2021

Healthcare Services

Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.

HiberCell Acquires Genuity Science, Inc.

August 16, 2021

Biotechnology

HiberCell, a clinical-stage oncology company, acquired Genuity Science, a genomics and multi‑omic analytics company with an advanced AI/ML platform, to integrate next‑generation computational capabilities into its translational oncology efforts. The stock acquisition brings Genuity and its subsidiaries into HiberCell, provides approximately $100 million in cash and existing partnership earnouts, and is intended to accelerate HiberCell's clinical programs and expand its preclinical pipeline.

Caprion-HistoGeneX Acquires Clinical Logistics Inc.

January 7, 2021

Healthcare Services

Caprion-HistoGeneX, a portfolio company backed by Arsenal Capital Partners, has acquired Clinical Logistics Inc. (CLI), a Halifax-based virtual central specimen management CRO. The acquisition expands Caprion-HistoGeneX’s specimen logistics and kitting capabilities to better support global clinical trial operations and specialty specimen handling for pharmaceutical and biotech customers.